Organize PDUFA V Patient-Focused Meetings Around Disease Clusters, Advocates Say
Executive Summary
Patient groups urge FDA not to limit 20 meetings over the next five years to specific diseases, as the agency has proposed, but instead to take a broader view on diseases based upon similar characteristics, quality-of-life burden and available treatment options.